Outlook on the Hydroxychloroquine Global Market to 2027 - Opportunity Analysis and Industry Forecast
05 janv. 2021 05h38 HE
|
Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Hydroxychloroquine Market by Product type, Distribution Channel, and Disease: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has...
Rising Prevalence of Rheumatoid Arthritis Across the Globe to Boost the Growth of Global Hydroxychloroquine Market by 2027 – Exclusive Report by Research Dive
02 nov. 2020 09h00 HE
|
Research Dive
New York, USA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- According to a Research Dive published report, the global hydroxychloroquine market is predicted to grow at a significant rate and generate strong...
Association of American Physicians & Surgeons (AAPS) Warns against More Devastating, Unwarranted Lockdowns
29 oct. 2020 13h57 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Oct. 29, 2020 (GLOBE NEWSWIRE) -- This election year presents an unprecedented medical issue, observes the Association of American Physicians & Surgeons (AAPS): whether Americans...
Americans Need COVID Treatment NOW, States the Association of American Physicians & Surgeons (AAPS)
20 oct. 2020 15h55 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Americans, even one who is as carefully shielded as the President of the United States, continue to be infected with COVID-19. The Association of...
MATEON’S PHASE 2 GLOBAL STUDY FOR OT-101/ TGF-β INHIBITOR AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN ARGENTINA.
19 oct. 2020 07h00 HE
|
Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (“Mateon” or the “Company”) (OTCQB:MATN) announced today the receipt of approval from Republica Argentina – Poder...
TLC Enrolls First Subject in Phase I Clinical Trial of Inhalable Anti-COVID-19 Program (TLC19)
14 oct. 2020 04h41 HE
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 14, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
Hydroxychloroquine Market to Reach $4.6 Billion by 2027 | CAGR: 7.9%: AMR
12 oct. 2020 09h44 HE
|
Allied Market Research
Portland, OR, Oct. 12, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global hydroxychloroquine market was pegged at $1.9 billion by 2019, and is projected to...
TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
06 oct. 2020 23h53 HE
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 07, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
Hydroxychloroquine Market to Reach USD 2,339.1 Million with 5.5% CAGR by 2027; Increasing Demand for the Product Will provide Impetus to Market Growth, says Fortune Business Insights™
01 oct. 2020 07h36 HE
|
Fortune Business Insights
Pune, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The global hydroxychloroquine market size is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will...
FDA Is Hoarding Life-saving Drugs While Americans Die, States the Association of American Physicians & Surgeons (AAPS) in Lawsuit
02 sept. 2020 12h51 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Sept. 02, 2020 (GLOBE NEWSWIRE) -- In a brief filed Sep 1 in its case demanding that the U.S. Food and Drug Administration (FDA) release the hydroxychloroquine (HCQ) in the Strategic...